• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Powershares Dynamic Biotechnology & Genome Portfolio

+ Add to Watchlist

PBE:US

50.0800 USD 0.7200 1.46%

As of 20:04:02 ET on 10/30/2014.

Snapshot for Powershares Dynamic Biotechnology & Genome Portfolio (PBE)

Open: 49.3600 High - Low: 50.2130 - 49.1500 Primary Exchange: NYSE Arca
Volume: 63,741 52-Week Range: 33.9600 - 50.2130 Beta vs DZOTR: 0.9992

ETF Chart for PBE

No chart data available.
  • PBE:US 50.0800
  • 1D
  • 1M
  • 1Y
49.3600
Interactive PBE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PBE

PowerShares Dynamic Biotechnology & Genome Portfolio is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the price and yield of the Dynamic Biotechnology & Genome Intellidex Index, a fundamentally-weighted index. Securities shown to possess the greatest capital appreciation potential are selected by the Index.

Inception Date: 2005-06-23 Telephone: 1-800-983-0903
Managers: PETER HUBBARD
Web Site: www.powershares.com

Fundamentals for PBE

NAV (on 2014-10-30) 50.0974
Assets (M) (on 2014-10-30) 428.3328
Shares out (M) 8.55
Market Cap (M) 428.18
% Premium -0.03
Average 52-Week % Premium 0.0120
Fund Leveraged N

Dividends for PBE

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-09-19) 0.0429
Dividend Yield (ttm) 0.55%

Performance for PBE

1-Month +8.35% 1-Year +41.67%
3-Month +13.74% 3-Year +34.39%
Year To Date +36.01% 5-Year +27.02%
Expense Ratio 0.63

Top Fund Holdings for PBE

Filing Date: 10/30/2014
Name Position Value % of Total
Sigma-Aldrich Corp 193,912 26,290,589 6.136%
Amgen Inc 144,690 23,379,010 5.456%
Alexion Pharmaceuticals Inc 119,126 22,982,979 5.364%
Regeneron Pharmaceuticals Inc 57,534 22,599,355 5.274%
Pharmacyclics Inc 162,126 21,821,349 5.093%
Illumina Inc 112,438 21,747,758 5.076%
Gilead Sciences Inc 187,459 21,411,567 4.997%
Biogen Idec Inc 58,789 18,871,269 4.404%
Repligen Corp 577,129 14,711,018 3.433%
Insys Therapeutics Inc 311,441 13,077,408 3.052%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil